Hong Kong Commercial Services Stock News

Abbisko Cayman (SEHK:2256) just kicked off a Phase II trial for its oral PD-L1 inhibitor, ABSK043, combined with Glecirasib. The trial targets non-small cell lung cancer patients with the KRAS G12C mutation. See our latest analysis for Abbisko Cayman. Abbisko Cayman's launch of its latest clinical trial comes after a remarkable period for shareholders. The 1-year total shareholder return is an impressive 237.82%, while the stock has more than tripled year-to-date. The momentum has been...

As global markets navigate a complex landscape marked by mixed performances and geopolitical developments, Asia's stock markets present intriguing opportunities for investors. With Japan's record highs and China's cautious optimism amid trade discussions, identifying undervalued stocks becomes crucial in capitalizing on potential market inefficiencies. In this context, understanding the fundamentals that make a stock undervalued—such as strong financial health, growth potential, and favorable...

Key Insights Newton Resources' significant private companies ownership suggests that the key decisions are influenced...

The Asian markets have been closely watched as global economic dynamics shift, with the recent U.S.-China trade truce providing a temporary boost to investor sentiment. In this context, penny stocks, though often overlooked, can present intriguing opportunities when they exhibit robust financial health. These smaller or newer companies hold potential for growth and value that larger firms might not offer, and we will explore three such compelling stocks in the Asian market.

As global markets navigate a complex landscape of interest rate adjustments and trade negotiations, Asian markets are also experiencing notable developments. With Japan's stock markets reaching record highs and China focusing on domestic demand to bolster growth, investors are increasingly interested in dividend stocks as a potential source of steady income amidst these shifting economic conditions. A good dividend stock often combines reliable payouts with the ability to adapt to evolving...

Guoquan Food (Shanghai) SEHK:2517 expanded its retail network by 98% in Q3 2025, adding more than 360 new instant retail stores. This surge aligns with marked gains in year-on-year revenue and core operating profit. See our latest analysis for Guoquan Food (Shanghai). After Guoquan Food’s rapid rollout of new stores and jump in core profit, momentum is clearly building as its share price climbed nearly 20% over the past month with a year-to-date share price return of 106%. In total,...

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...

With a median price-to-earnings (or "P/E") ratio of close to 13x in Hong Kong, you could be forgiven for feeling...

While 3SBio Inc. ( HKG:1530 ) shareholders have enjoyed a good week with stock up 10%, they need remain vigilant. In...

The board of directors of Hansoh Pharmaceutical Group announced that China's National Medical Products Administration has accepted the New Drug Application for HS-10365 capsules, a selective RET inhibitor for treating adult patients with RET fusion-positive locally advanced or metastatic non-small cell lung cancer. This regulatory milestone not only reflects progress in Hansoh’s oncology pipeline, but also highlights the company’s potential to address significant unmet needs in lung cancer...

Impro Precision Industries (SEHK:1286) just posted a strong year-on-year jump in third quarter revenue, with standout gains in its diversified industrials and AI-related segments. The company’s positive sales outlook continues to draw attention from investors. See our latest analysis for Impro Precision Industries. Momentum has clearly shifted in Impro Precision Industries’ favor, with the share price climbing 12.87% over the past month and surging 65% in the last quarter. That is part of a...

Key Insights Significant control over TUHU Car by individual investors implies that the general public has more power...

The Veeko International Holdings Limited ( HKG:1173 ) share price has softened a substantial 35% over the previous 30...

Those holding Magnus Concordia Group Limited ( HKG:1172 ) shares would be relieved that the share price has rebounded...

Oi Wah Pawnshop Credit Holdings Limited ( HKG:1319 ) will increase its dividend on the 28th of November to HK$0.01...

Those holding Best Food Holding Company Limited ( HKG:1488 ) shares would be relieved that the share price has...

China Environmental Technology and Bioenergy Holdings Limited ( HKG:1237 ) shareholders won't be pleased to see that...

Fengyinhe Holdings Limited ( HKG:8030 ) shares have continued their recent momentum with a 38% gain in the last month...

What are the early trends we should look for to identify a stock that could multiply in value over the long term? In a...

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...

Crystal International Group's (HKG:2232) stock is up by a considerable 18% over the past three months. Since the market...

CARsgen Therapeutics Holdings (SEHK:2171) has caught investor attention with an active streak of recent updates. In the past days, the company rolled out promising clinical trial results and approved a sizeable share buyback program. See our latest analysis for CARsgen Therapeutics Holdings. Despite a steep 12% decline in the past month, CARsgen’s share price has surged 76% year to date, reflecting renewed optimism driven by its clinical breakthroughs and buyback momentum. The company’s one...

Moon (SEHK:1723) remains unprofitable, with losses accelerating at a rapid pace of 74.3% per year over the last five years and no improvement in margins. The company’s shares are trading at a steep Price-to-Sales Ratio of 7.4x, far surpassing both its peer average of 0.1x and the broader Hong Kong electronic industry average of 0.5x. This implies that the current market price of HK$3.06 is well above the estimated fair value of HK$0.23. With no signs of profit growth, continued share...

Kinetic Development Group recently increased its stake in MC Mining to approximately 40.13% through completed share subscription tranches, with ambitions to reach a 51% holding as the Makhado Project in South Africa advances towards key infrastructure milestones by December 2025. This move highlights Kinetic’s intention to deepen its involvement in the mining sector and signals confidence in the development potential of the Makhado asset. We'll examine how Kinetic's push for majority...